US Stock MarketDetailed Quotes
CTRVP HEPION PHARMACEUTICALS INC PREFERRED STOCK
- 0.000
- +0.000+0.00%
15min DelayClose Jul 5 09:33 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low52Volume0.000Open0.000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.00052wk High0.00P/B0Float Cap0.00052wk Low--Dividend TTM0Shs Float0.000Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low0.000Avg Price1Lot Size
About HEPION PHARMACEUTICALS INC PREFERRED STOCK Company
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Edison, NJ.
Company Profile
SymbolCTRVP
Company NameHEPION PHARMACEUTICALS INC PREFERRED STOCK
Listing DateFeb 27, 2015
Founded2013
CEOMr. John T. Cavan
MarketPink Market
Employees22
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address399 Thornall Street,1st Floor
CityEdison
ProvinceNew Jersey
CountryUnited States of America
Zip Code08837
Phone1-732-902-4000
Websitehttp://www.hepionpharma.com
Company Executives
- Name
- Position
- Salary
- John T. Cavan
- Interim Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer
- 400.00K
- John Patrick Brancaccio
- Executive Chairman of the Board
- 81.00K
- Michael Purcell
- Director
- --
- Dr. Kaouthar Lbiati, M.D.
- Independent Director
- 80.50K
- Dr. Timothy Block, PhD
- Independent Director
- 72.90K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg